Skip to main content

Loading market ticker...

Wanbury

Healthcare NSE:WANBURY

300.20INR
14.25 ( 4.98%)

Last update at May 27, 2026, midnight

Day Range

287.00300.20
LowHigh

52 Week Range

154.01 329.70
LowHigh

Fundamentals

  • Previous Close 285.95
  • Market Cap 7733.21M
  • Volume129,746
  • P/E Ratio 14.75
  • EBITDA 955.26M
  • Revenue TTM 6311.24M
  • Revenue Per Share TTM 192.24
  • Gross Profit TTM 3357.54M
  • Diluted EPS TTM 14.97

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1427.60 15/05/26 15/05/26 Same Day Short Term Healthcare 0.17%
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 295.51M 563.37M -102.87M 811.28M -124.06M
Net income 305.30M 559.56M -103.96M 814.74M -126.06M
Total Revenue 5995.14M 5744.78M 4981.75M 5111.86M 3871.03M
Gross Profit 3050.39M 2652.98M 1891.54M 2038.22M 1608.95M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 4139.17M 3434.93M 3038.70M 3525.49M 2891.76M
Intangible assets 2.28M 2.66M 0.89M 1.01M 2.28M
Other current assets 265.45M 94.68M 273.88M 322.51M 0.00M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 6.60M 19.06M -210.32M 125.25M 73.40M
Operating Cash 261.02M 39.78M 197.97M 405.23M 166.82M
Free Cash Flow -229.26M -134.45M 71.69M 308.65M 122.54M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
WANBURY
Wanbury 		14.25 4.98% 300.20 7733.21 14.75
SUNPHARMA
Sun Pharmaceutical Industries Limited 		3.50 0.19% 1844.30 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		44.50 0.66% 6797.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		85.70 1.92% 4537.80 1362716.66 63.48
CIPLA
Cipla Limited 		0.70 0.05% 1418.20 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.